CS logo
small CS logo
Campus Neurologico Senior

Torres Vedras, Portugal
Private hospital in Torres Vedras
Bairro de Santo António 47, 2560-280 Torres Vedras

About Campus Neurologico Senior


"É um espaço único na área da saúde na Europa, que foca a sua intervenção no tratamento, reabilitação e investigação de doenças neurológicas."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Campus Neurológico Sénior
3
Theravance Biopharma
3
Amgen
2
Biogen
2
Celgene
2
Hoffmann-La Roche
1
NeuroDerm Ltd.
1
Total Rows: 7

Clinical Trials at Campus Neurologico Senior


During the past decade, Campus Neurologico Senior conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221100116633000000000011Started TrialsCompleted Trails20152016201720182019202002468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-08-13
2019-08-08
Terminated
1,653
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes
2016-11-01
2017-05-30
Completed
20
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-01-24
2021-07-21
Completed
195
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
2019-02-22
2021-11-10
Terminated
203
Feasibility of the AHA Exergame System in Parkinson's Disease Patients
2018-06-01
2018-09-30
Completed
10
A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache
2019-10-07
2023-06-14
Active, not recruiting
620

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Campus Neurologico Senior" #1 sponsor was "Campus Neurológico Sénior" with 3 trials, followed by "Theravance Biopharma" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Biogen" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Campus Neurologico Senior" #1 collaborator was "University of Lisbon" with 2 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCampus Neurológico Sénior: 3Campus Neurológico Sénior: 3Theravance Biopharma: 3Theravance Biopharma: 3Amgen: 2Amgen: 2Biogen: 2Biogen: 2Celgene: 2Celgene: 2Hoffmann-La Roche: 1Hoffmann-La Roche: 1NeuroDerm Ltd.: 1NeuroDerm Ltd.: 1

Created with Highcharts 11.1.0Top CollaboratorsUniversity of Lisbon: 2University of Lisbon: 2Johns Hopkins University: 1Johns Hopkins University: 1

Clinical Trials Conditions at Campus Neurologico Senior


According to Clinical.Site data, the most researched conditions in "Campus Neurologico Senior" are "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Parkinson Disease" (2 trials) and "MSA" (1 trials). Many other conditions were trialed in "Campus Neurologico Senior" in a lesser frequency.

Clinical Trials Intervention Types at Campus Neurologico Senior


Most popular intervention types in "Campus Neurologico Senior" are "Drug" (11 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "ampreloxetine" (3 trials), "AHA Exergame System" (1 trials), "Aducanumab" (1 trials) and "Aducanumab (BIIB037)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Campus Neurologico Senior


The vast majority of trials in "Campus Neurologico Senior" are 14 trials for "All" genders.

Clinical Trials Status at Campus Neurologico Senior


Currently, there are NaN active trials in "Campus Neurologico Senior". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Campus Neurologico Senior, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Campus Neurologico Senior, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Not Applicable: 3Not Applicable: 3Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Active, not recruiting: 3Active, not recruiting: 3Terminated: 3Terminated: 3Recruiting: 2Recruiting: 2Unknown status: 1Unknown status: 1